Amwill Health Care Limited (BOM:544353)

India · Delayed Price · Currency is INR

43.40

+1.65 (3.95%)

At close: Aug 17, 2026

-30.56% (1Y)

Market Cap	868.16M -30.6%
Revenue (ttm)	454.92M +12.1%
Net Income	114.21M +6.4%
EPS	5.71 -13.9%
Shares Out	20.00M
PE Ratio	7.60
Forward PE	n/a
Dividend	0.50 (1.20%)
Ex-Dividend Date	Aug 7, 2026

Volume	2,400
Open	41.75
Previous Close	41.75
Day's Range	41.75 - 43.40
52-Week Range	28.91 - 62.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 18, 2026

About Amwill Health Care

Amwill Health Care Limited, a derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India. It offers product formulations for anti-acne, dry skin, anti-aging, anti-fungal, anti-histaminic, anti-perspirant, antibiotics, skin lightening, hair care, steroid and keratolytic, sunscreen, vitiligo, miscellaneous, peri-orbital hyperpigmentation, anti-scar, topical antibiotics, antioxidants, and anti-scabies, as well as cosmeceutical and aesthetic categories. The company was founded in 2009 ... [Read more]

Industry Pharmaceutical Preparations

Founded 2009

Employees 88

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544353

Full Company Profile

Financial Performance

In fiscal year 2026, Amwill Health Care's revenue was 454.92 million, an increase of 12.10% compared to the previous year's 405.82 million. Earnings were 114.21 million, an increase of 6.44%.

Financial Statements